Safety Shot Inc (SHOT)
NASDAQ: SHOT · IEX Real-Time Price · USD
1.150
-0.040 (-3.36%)
At close: Jul 2, 2024, 4:00 PM
1.160
+0.010 (0.87%)
After-hours: Jul 2, 2024, 7:58 PM EDT
Company Description
Safety Shot, Inc., a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property.
The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content.
It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen.
The company sells its products through distributors, retailers, and e-commerce websites. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023.
Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.
Safety Shot Inc
| Country | United States |
| Founded | 2018 |
| IPO Date | Oct 30, 2020 |
| Industry | Beverages - Non-Alcoholic |
| Sector | Consumer Staples |
| Employees | 8 |
| CEO | Jarrett A. Boon |
Contact Details
Address: 1061 E. Indiantown Rd., Ste. 110 Jupiter, Florida 33477 United States | |
| Phone | 561-325-0482 |
| Website | jupiterwellness.com |
Stock Details
| Ticker Symbol | SHOT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $7.50 |
| CIK Code | 0001760903 |
| ISIN Number | US48208F1057 |
| Employer ID | 83-2455880 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Jarrett A. Boon | Chief Executive Officer and Director |
| Brian Scott John | Advisor |
| Jordan Schur | President and Director |
| Danielle De Rosa-Diaz | Chief Financial Officer |
| David Sandler CSCS, FISSN, FNSCA, HFD, HFS, M.S., MS, RSCC | Chief Operating Officer |
| Anthony Pedicelli | Director of Marketing |
| Dr. Andy Goren M.D. | Chief Medical Officer and Member of Scientific Advisory Board |
| Josh Wagner | Chief Revenue Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 2, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 28, 2024 | 8-K | Current Report |
| Jun 27, 2024 | 8-K | Current Report |
| Jun 26, 2024 | 8-K | Current Report |
| Jun 25, 2024 | 8-K | Current Report |
| Jun 24, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 24, 2024 | DEF 14A | Other definitive proxy statements |
| Jun 10, 2024 | 4 | Statement of changes in beneficial ownership of securities |
| Jun 10, 2024 | PRE 14A | Other preliminary proxy statements |
| Jun 6, 2024 | 8-K | Current Report |